stage III melanoma

Known as: Stage III Skin Melanoma AJCC v6, stage III cutaneous melanoma, Stage III Melanoma of the Skin AJCC v6 
The tumor may be any thickness, with or without ulceration (a break in the skin), and one or more of the following is true: (1) cancer has spread to… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
BACKGROUND Combination therapy with the BRAF inhibitor dabrafenib plus the MEK inhibitor trametinib improved survival in patients… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2016
Highly Cited
2016
BACKGROUND On the basis of data from a phase 2 trial that compared the checkpoint inhibitor ipilimumab at doses of 0.3 mg, 3 mg… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Prediction of outcome for melanoma patients with surgically resected macroscopic nodal metastases is very imprecise. We performed… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE Adjuvant pegylated interferon alfa-2b (PEG-IFN-α-2b) was approved for treatment of resected stage III melanoma in 2011… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Hypermethylation of the promoter region of tumor-related genes (TRGs) has been shown to silence gene expression during melanoma… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE To determine the survival rates and independent predictors of survival using a contemporary international cohort of… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Any benefit of adjuvant interferon alfa-2b for melanoma could depend on dose and duration of treatment. Our aim was to… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Inducible nitric oxide synthase (iNOS) produces nitric oxide, which has growth promoting activity in melanoma. A preliminary… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
HYPOTHESIS The clinical treatment of patients with stage IV melanoma according to criteria of the American Joint Committee on… (More)
  • table 1
  • figure 2
  • table 2
  • figure 3
  • figure 1
Is this relevant?
Highly Cited
1994
Highly Cited
1994
PURPOSE To perform a double-blind randomized trial with American Joint Commission on Cancer (AJCC) stage III melanoma patients… (More)
Is this relevant?